Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMART-FFR: Simplified Anti-Thrombotic Therapy for FFR
NCT02384070Completed
- Sponsor
- Odessa Heart Institute
- Start
- Jan 2009
- Primary completion
- Dec 2013
- Modality
- Peptides, Small Molecules
01
Overview
Randomised, double-blind trial of bivalirudin in coronary artery disease (CAD) (3 arms), sponsored by Odessa Heart Institute. Primary endpoint: Thrombotic Complications at 30 days. Started Jan 2009; status: completed.
02
Drugs
bivalirudin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02384070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02384070.